Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2007; 13(18): 2622-2625
Published online May 14, 2007. doi: 10.3748/wjg.v13.i18.2622
Published online May 14, 2007. doi: 10.3748/wjg.v13.i18.2622
Figure 2 A: ESCC patients at stages III- IV(A) showing higher mRNA expression level of beta-catenin than ESCC patients at stages I-II(B).
Y: observed lymph node metastasis, N: no lymph node metastasis. ESCC patients with lymph node metastasis had higher mRNA expression level of beta-catenin than ESCC patients with no lymph node metastasis.
- Citation: Ji L, Cao XF, Wang HM, Li YS, Zhu B, Xiao J, Wang D. Expression level of beta-catenin is associated with prognosis of esophageal carcinoma. World J Gastroenterol 2007; 13(18): 2622-2625
- URL: https://www.wjgnet.com/1007-9327/full/v13/i18/2622.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i18.2622